The most prevalent grade 3/4 non-hematologic effects were hand-foot syndrome (24.0%), proteinuria (4.0%), hypertension (36.0%), increased ALT (4.0%), and tiredness (8.0%). This evidence concerns the gene GPT and hypertensive disorder.